Difference between revisions of "Novartis"
(affiliations) |
(adding Business Insights) |
||
| Line 1: | Line 1: | ||
| − | ==PR | + | ==PR, Lobbying firms and Corporate Services== |
*[[APCO Worldwide]] | *[[APCO Worldwide]] | ||
| + | |||
| + | In 2008, Novartis is listed as a client for [[Business Insights]]<ref> Business Insights [http://globalbusinessinsights.com/content/rbhc0019m.pdf Patient Power: The shift towards more informed, more powerful consumers of drugs] Accessed 5th February 2008</ref> | ||
==Affiliations== | ==Affiliations== | ||
Revision as of 14:47, 12 February 2008
PR, Lobbying firms and Corporate Services
In 2008, Novartis is listed as a client for Business Insights[1]
Affiliations
Novartis provided generous support for the Expert Consensus Guideline Series: Treatment of Schizophrenia 1999 an initiative aiming at establishing uniform medication guidelines for schizophrenia[2]. It is reported that this was an initiative 'supported exclusively by 6 pharmaceutical companies: Eli Lilly and Company, Janssen Pharmaceutica Inc., Novartis Pharmaceuticals Corporation, Ortho-McNeil Pharmaceutical, Pfizer Inc. and Zeneca Pharmaceuticals' (now known as AstraZeneca). Michael Hogan and Laurie Flynn were also involved in this initiative.
References
- ↑ Business Insights Patient Power: The shift towards more informed, more powerful consumers of drugs Accessed 5th February 2008
- ↑ Weibert, S. The Genesis of President Bush’s New Freedom Commission on Mental Health Teenscreen Truth. Accessed 9th January 2008
